Navigation Links
Randomize Gene Sequences with New PCR Mutagenesis Kit



GeneMorph PCR mutagenesis kit produces a unique mutational spectrum

Janice Cline Holly Hogrefe

Stratagene

The GeneMorph PCR mutagenesis kit simplifies the process of constructing mutant libraries for protein evolution and structure-function studies. Errors are introduced during PCR at low, moderate, or high mutation frequencies using a single set of optimal reaction conditions. The kit features Mutazyme DNA polymerase, a novel error-prone DNA polymerase mutant developed at Stratagene. Mutazyme DNA polymerase produces all possible transition and transversion mutations with minimal bias, and its mutational spectrum is distinct from that of Taq DNA polymerase. Unlike current Taq- based protocols, the GeneMorph method is robust and can be applied to mutagenesis of long targets (1-10 kb).

Error-prone PCR is a random mutagenesis technique for introducing amino acid changes into proteins. Mutations are deliberately introduced during PCR through the use of error-prone DNA polymerases and reaction conditions.1,2 Randomized DNA sequences are cloned into expression vectors, and the resulting mutant libraries are screened for altered or improved protein activity. To analyze structure-function relationships, mutation frequencies of one amino acid change (1-2 nucleotide changes) per gene are desired, while directed evolution studies typically empl
'"/>

Source:


Page: All 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. New Yeast Cloning System for Producing Proteins with Native Amino Acid Sequences
2. Selecting siRNA Sequences to Incorporate into the pSilencer Vectors
3. Big Blue Rodent Cell Cultures for Mutagenesis Studies
4. High-Efficiency Site-Directed Mutagenesis of Large Plasmid Vectors
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Randomize Gene Sequences with New PCR Mutagenesis Kit

(Date:12/14/2009)... -- Dyadic International, Inc. (Pink Sheets: DYAI) ("Dyadic") ... with The Scripps Research Institute ("Scripps") by entering ... genome of Dyadic,s patented and proprietary C1 fungus ... the successful relationship between the two organizations which ... to annotate the C1 genome for the first ...
(Date:12/14/2009)... N.J., Dec. 14 The third edition ... , published by the Infusion ... treatment for anthracycline extravasation.(1) Anthracyclines are a ... and epirubicin that have been used in the ... early 1970s.(2) ,, According to the ...
(Date:12/14/2009)... -- Lionbridge (Nasdaq: LIOX ) today ... three-year master services agreement with a multi-billion ... that serve patients in approximately 100 countries. ... sole provider for translation of the company,s ... human resources, legal, and corporate communications information. ...
(Date:12/14/2009)... Decision Resources, one of the world,s ... healthcare issues, finds that, owing to the launches ... market will increase more than sevenfold from $790 ... in the United States, France, Germany, Italy, Spain, ... Pharmacor report entitled Atrial Fibrillation finds ...
Breaking Biology Technology:Dyadic International Extends Collaboration With The Scripps Research Institute 2Dyadic International Extends Collaboration With The Scripps Research Institute 3Dyadic International Extends Collaboration With The Scripps Research Institute 4Dyadic International Extends Collaboration With The Scripps Research Institute 5Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 2Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 3Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 4Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 5Multi-Billion Dollar Biotech Firm Chooses Lionbridge as Exclusive Translation Provider with Three-Year Master Services Agreement 2Multi-Billion Dollar Biotech Firm Chooses Lionbridge as Exclusive Translation Provider with Three-Year Master Services Agreement 3The Atrial Fibrillation Drug Market Will Increase More Than Sevenfold, from $790 Million in 2008 to $6.1 Billion in 2018 2
... WHO and CDC have stated that the,predictive accuracy ... -- often correct less than 50% of the time,especially ... yet accurate in,our predictions of upcoming influenza strains, approximately ... States alone., As in the case of hurricanes, ...
... (Nasdaq: TPTX ) today announced financial results for ... period, the Company posted,revenue of $1.2 million and a ... $14.3 million at September 30, 2008., "The past ... transition to a development-only company," said Ev Graham, acting ...
... /Xinhua-PRNewswire-FirstCall/ -- China Shenghuo,Pharmaceutical Holdings, Inc. (Amex: ... which is engaged in the research, development, ... cosmetic products,in the People,s Republic of China, ... (formerly the American Stock Exchange) (the "Exchange") ...
Other Biology Technology:A New Way to Predict Outbreaks: Replikin Peptide Concentration in H5N1 Influenza Virus Genome as a Marker for Lethal Outbreaks 2A New Way to Predict Outbreaks: Replikin Peptide Concentration in H5N1 Influenza Virus Genome as a Marker for Lethal Outbreaks 3TorreyPines Therapeutics Reports Third Quarter 2008 Results and Recent Accomplishments 2TorreyPines Therapeutics Reports Third Quarter 2008 Results and Recent Accomplishments 3TorreyPines Therapeutics Reports Third Quarter 2008 Results and Recent Accomplishments 4TorreyPines Therapeutics Reports Third Quarter 2008 Results and Recent Accomplishments 5TorreyPines Therapeutics Reports Third Quarter 2008 Results and Recent Accomplishments 6TorreyPines Therapeutics Reports Third Quarter 2008 Results and Recent Accomplishments 7NYSE Alternext US Accepts China Shenghuo's Compliance Plan for Continued Listing 2NYSE Alternext US Accepts China Shenghuo's Compliance Plan for Continued Listing 3NYSE Alternext US Accepts China Shenghuo's Compliance Plan for Continued Listing 4
(Date:12/16/2009)... HARBOR, Fla., Dec. 2 Communication ... a leading supplier of electronic signature solutions ... industry* and the recognized leader** in biometric ... a leading International Electronic Document Management (EDM) ... entered an agreement to provide their products ...
(Date:12/16/2009)... CHURCH, Va., Dec. 9 CSC ... that the American Association for Laboratory Accreditation ... Commission (ISO/IEC) 17025:2005 accreditation to the company,s ... CSC Identity Labs located in Fairmont, W.Va. ... test laboratory in the world to achieve ...
(Date:12/15/2009)... signed an agreement with the British Society for Research ... the journal Biogerontology for an initial period ... member of the Biogerontology editorial board and ... Springer will sponsor the society and provide society members ... www.springerlink.com . , Biogerontology offers a ...
Breaking Biology News(10 mins):CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 2CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 3CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 4CSC's Identity Management and Biometric Test Lab Achieves ISO/IEC 17025 Accreditation 2Greenway Medical Technologies Plays Leading Role in Interoperability Demonstrations at Seventh Annual Public Health Information Network 28PHIN 29 Con 13987 1Greenway Medical Technologies Plays Leading Role in Interoperability Demonstrations at Seventh Annual Public Health Information Network 28PHIN 29 Con 13987 2Greenway Medical Technologies Plays Leading Role in Interoperability Demonstrations at Seventh Annual Public Health Information Network 28PHIN 29 Con 13987 3Greenway Medical Technologies Plays Leading Role in Interoperability Demonstrations at Seventh Annual Public Health Information Network 28PHIN 29 Con 13987 4MultiVu Video Feed 3A POSITIVE PHASE 3 TRIAL DATA FOR INVESTIGATIONAL NEW MIGRAINE TREATMENT PRESENTED IN LATE BREAKING SESSION AT 14th ANNUAL INTERNA 4962 1MultiVu Video Feed 3A POSITIVE PHASE 3 TRIAL DATA FOR INVESTIGATIONAL NEW MIGRAINE TREATMENT PRESENTED IN LATE BREAKING SESSION AT 14th ANNUAL INTERNA 4962 2Replication at DNA damage sites highlights Fanconi anemia and breast cancer proteins 56805 1Replication at DNA damage sites highlights Fanconi anemia and breast cancer proteins 56805 2
... leading study that has implications for the development of ... ovarian cancers that have lost the expression of a ... the loss of the GPC3 gene induces overgrowth through ... cancer growth. , Published today in Developmental Cell, the ...
... May 12, 2008 There exists much ethical controversy brought ... to religion. In a new essay in The Journal of ... medical ethics that draws upon Jewish texts, traditions, and philosophy ... of this faith tradition. , Genetic explanations for how ...
... new project (RevGenUK) is being launched at the John Innes ... , This knowledge can be used to improve the ... grow more sustainably with reduced nitrogen fertilisers. , ... and Biological Sciences Research Council (BBSRC), the project builds on ...
Other Biology News:Religion and the narrative of biological science 2
... These handy dispensers save space and ... and other garb. They are the ... parts used in labs, processing and ... charges and the particles they attract. ...
... 2 NaO 7 S 2 Formula Weight: ... Identity: By IR epsilon max (615 nm, ... equal to 60 x 10 3 Loss ... lambda max (H 2 O solution): ...
...
... FP-6500 is the research-grade spectrofluorometer with a ... sensitivity S/N ratio 200 or greater for ... is especially designed to keep in mind ... as kinetics, stopped-flow, titration, or anisotropic measurements. ...
Biology Products: